JPRN-UMIN000023902已完成未知
An exploratory clinical study of the renoprotective effect of empagliflozin and the verification of companion diagnostics in type 2 diabetes patients - Renoprotection and companion diagnostics verification in type 2 diabetes patients treated with empagliflozin (RECOVERY)
Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences0 个研究点目标入组 51 人开始时间: 2016年9月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Those with past histories of hypersensitivity to SGLT2 inhibitors 2) Those with severe ketosis, diabetic coma or precoma 3) Those at perioperative stages, or those with severe infection or serious injury 4) Those with followings: 1. Hypopituitarism or adrenal insufficiency 2. Malnutrition, starvation, irregular or insufficient food intake, or debilitating condition 3. Excessive muscular exercise 4. Excessive alcohol drinker 5 ) Those with urinary tract or genital infection 6) Those with severe liver dysfunction 7) Those who are pregnant or hoping pregnancy 8) Those with a malignant tumor currently or in the past 5 years 9) Those who are treated currently with SGLT2 inhibitors 10) Those who are considered not eligible for the study by attending doctors because of any medical reasons
研究者
相似试验
尚未招募
4 期
In diabetes patients with kidney disease, which drug is better between pentoxifylline & dapagliflozin as an add on therapy to metformin, glimepiride & telmisartan in terms of kidney protection?CTRI/2023/10/059044Bhagat Phool Singh Govt. Medical College For Women
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
未知
不适用
Romdomized study to evaluate the renoprotective effects of clarithromycin for diabetic patients with microalbuminuria.Diabetic nephropathyJPRN-C000000303Okayama university graduate school of medicine, dentistry and pharmaceutical sciences, Department of medicine and clinical science40
已完成
不适用
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failurechronic heart failure, chronic kidney diseaseJPRN-UMIN000036119Kawashima hospital40
进行中（未招募）
1 期
This study aims to investigate the potential beneficial effects on the kidney of a new medication called Dapagliflozin in type 2 diabetic patients.Diabetic NephropathyEUCTR2013-004042-42-GBKing’s College London40